HLCL-61
编号: 16062204
Cas号: 586395-74-6
纯度: 98% by HPLC
HLCL-61 is a potent and selective PRMT5 inhibitor for treatment of acute myeloid leukemia. HLCL-61 resulted in significantly increased expression of miR-29b and consequent suppression of Sp1 and FLT3 in AML (acute myeloid leukemia) cells. As a result, significant antileukemic activity was achieved. The increased PRMT5 activity enhanced AML growth in vitro and in vivo while PRMT5 downregulation reduced it. In AML cells, PRMT5 interacted with Sp1 in a transcription repressor complex and silenced miR-29b preferentially via dimethylation of histone 4 arginine residue H4R3.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | HLCL-61 |
|---|---|
| Iupac 化学名称 | 1-(9-ethyl-9H-carbazol-3-yl)-N-(2-methoxybenzyl)methanamine hydrochloride |
| 同义词 | HLCL 61; HLCL-61. |
| 英文同义词 | HLCL 61; HLCL-61. |
| 分子式 | C23H25ClN2O |
| 分子量 | 380.916 |
| Smile | Cl.C(C)N1C2=CC=CC=C2C=2C=C(C=CC12)CNCC1=C(C=CC=C1)OC |
| InChiKey | XYAVCNMZZKTEGR-UHFFFAOYSA-N |
| InChi | InChI=1S/C23H24N2O.ClH/c1-3-25-21-10-6-5-9-19(21)20-14-17(12-13-22(20)25)15-24-16-18-8-4-7-11-23(18)26-2;/h4-14,24H,3,15-16H2,1-2H3;1H |
| Cas号 | 586395-74-6 |
| 相关CAS号 |
订购信息
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
